Navigation Links
AACR news: Misregulated genes common to tobacco-related cancers offer potential new prognostic tool
Date:4/9/2013

Believe it or not, while researchers have explored which genes are mutated in each type of tobacco-associated cancer, until now no one had thought to look across these types for common genes that might predict patient outcomes. Results presented at the AACR Annual Meeting 2013 show that in lung and bladder cancers, genes related to the regulation of the cell cycle are associated with poor patient outcomes.

"We ultimately envision this as a prognostic tool to predict survival rates for people with tobacco related cancers. Recognizing patients with high expression of these genes could help us predict risk and so match patients with the most appropriate treatments," says Garrett Dancik, PhD, postdoc in the lab of Dan Theodorescu, MD, PhD, director of the University of Colorado Cancer Center.

The study mined data from publicly-available tumor registries that included a total of 1996 samples of cancer types including lung adenocarcinoma, squamous cell lung carcinoma, bladder transitional cell carcinoma, and head and neck squamous cell carcinoma. The question was this: what common genetic signatures would correlate with patient outcomes? Interestingly, researchers had previously asked this question of prostate cancer and had developed a panel of 31 cell-cycle related genes that predict the aggressiveness of the disease. Once Dancik and Theodorescu narrowed in on pathways controlling cell cycle as possibly predictive in tobacco-related cancers, they wondered if the same 31-gene panel might work with these cancers as well.

"Take out the squamous cell cancers and the panel is strongly predictive of patient outcomes," Dancik says. "This is a strong tool that could have a really useful application only it seems there's something unique going on with the squamous cell types of tobacco-associated cancers that's not true for the others."

In Dancik's opinion, the discovery of correlation between cell cycle gene signatures and patient outcomes is an important first step in developing new ways to predict the risks of tobacco-associated cancers. The work now is in integrating this finding with existing risk assessments.


'/>"/>

Contact: Garth Sundem
garth.sundem@ucdenver.edu
805-559-2023
University of Colorado Denver
Source:Eurekalert

Related biology news :

1. Good news: Fewer maternal and child deaths
2. REACH news: European ombudsman takes up PETA complaint
3. AACR news: Paragazole excels in preclinical models of triple-negative breast cancer
4. AACR news: Six2 homeoprotein allows breast cancer cells to detach and metastasize
5. AACR news: Little molecule makes big difference in bladder cancer metastasis
6. AACR news: New target plus new drug equals death of melanoma cells
7. AACR news: K9 osteosarcoma samples identify drivers of metastasis in pediatric bone cancer
8. Fruit fly studies guide investigators to misregulated mechanism in human cancers
9. Planarian genes that control stem cell biology identified
10. Culprit behind unchecked angiogenesis identified
11. Researchers identify genes that may help in ovarian cancer diagnosis and prognosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... The research team of The Hong Kong Polytechnic University ... adopting ground breaking 3D fingerprint minutiae recovery and matching technology, pushing ... for use in identification, crime investigation, immigration control, security of access ... ... A research team led by Dr Ajay ...
(Date:3/27/2017)... , March 27, 2017  Catholic Health Services ... Management Systems Society (HIMSS) Analytics for achieving Stage ... Model sm . In addition, CHS previously earned ... hospitals using an electronic medical record (EMR). ... high level of EMR usage in an outpatient ...
(Date:3/23/2017)... , Mar. 23, 2017 Research and ... System Market Analysis & Trends - Industry Forecast to 2025" ... ... grow at a CAGR of around 8.8% over the next decade ... industry report analyzes the market estimates and forecasts for all the ...
Breaking Biology News(10 mins):
(Date:6/15/2017)... ... 15, 2017 , ... angelMD announced the closure of a ... angelMD’s SVP of Corporate Development, served as the syndicate leader for this first ... Saranas’ recently announced $4 million Series B financing round. , Saranas is working ...
(Date:6/15/2017)... ... June 15, 2017 , ... ... new guide on how to assemble a lab workstation. The guide outlines the ... include Adam’s Nimbus or Eclipse balance, AVT anti-vibration table, OIML/ASTM certified weights, and ...
(Date:6/14/2017)... ... 14, 2017 , ... The Thailand Board of Investment (BOI) ... co-hosting a delegation from Thailand at BIO 2017 in San Diego, CA taking ... the world, regroups more than 1,100 biotech companies, academic institutions, state biotechnology centers ...
(Date:6/14/2017)... USA – , ... ... June 14, 2017 -- Diagenode, a leading global provider ... has licensed a new technology specific for ChIP-sequencing from ... immunoprecipitation followed by sequencing (ChIP-seq) allows the study of ...
Breaking Biology Technology: